![](/img/cover-not-exists.png)
The Stat3/5 signaling biosignature in hematopoietic stem/progenitor cells predicts response and outcome in myelodysplastic syndrome patients treated with azacitidine
Miltiades, P., Lamprianidou, E., Vassilakopoulos, T. P., Papageorgiou, S. G., Galanopoulos, A., Kontos, C. K., Adamopoulos, P. G., Nakou, E., Vakalopoulou, S., Garypidou, V., Papaioannou, M., HatjiharLanguage:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-15-1288
Date:
December, 2015
File:
PDF, 866 KB
english, 2015